Quarterly Insider Transactions at Recursion Pharmaceuticals, Inc. (RXRX)
Shares Bought
Shares Sold
RXRX Insider transactions
| Quarter | Buy / Adquisition | Sell / Disposition | Net Activity | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Traded Shares | Avg. Price /p share | Transactions | Insiders | Traded Shares | Avg. Price /p share | Transactions | Insiders | |||
| Q4 2024 | 131K | $0.69 $90,014 | 8 | 6 | 110K | $6.36 $701,217 | 8 | 4 | 20.6K | |
| Q3 2024 | 978K | $1.21 $1.18 Million | 26 | 8 | 458K | $6.65 $3.04 Million | 26 | 5 | 520K | |
| Q2 2024 | 334K | $0.6 $201,240 | 20 | 9 | 633K | $7.9 $5 Million | 30 | 5 | (299K) | |
| Q1 2024 | 1.3M | $1.07 $1.39 Million | 35 | 8 | 652K | $10.14 $6.61 Million | 44 | 7 | 643K | |
| Q4 2023 | 448K | $1.28 $571,133 | 24 | 7 | 561K | $6.43 $3.61 Million | 34 | 6 | (114K) | |
| Q3 2023 | 565K | $1.52 $858,966 | 32 | 8 | 730K | $10.92 $7.97 Million | 62 | 6 | (165K) | |
| Q2 2023 | 545K | $0.74 $402,328 | 25 | 12 | 1.08M | $5.82 $6.3 Million | 31 | 6 | (537K) | |
| Q1 2023 | 2.4M | $3.06 $7.32 Million | 59 | 10 | 300K | $7.23 $2.17 Million | 41 | 5 | 2.1M | |
| Q4 2022 | 3.27M | $2.01 $6.57 Million | 32 | 9 | 250K | $9.48 $2.37 Million | 34 | 5 | 3.02M | |
| Q3 2022 | 229K | $0.56 $128,172 | 25 | 9 | 208K | $9.7 $2.02 Million | 28 | 4 | 21K | |
| Q2 2022 | 905K | $0.39 $354,350 | 76 | 8 | 549K | $6.06 $3.32 Million | 74 | 5 | 356K | |
| Q1 2022 | 1.7M | $0.42 $716,775 | 31 | 11 | 1.11M | $11.09 $12.3 Million | 15 | 6 | 587K | |
| Q4 2021 | 1.14M | $0.18 $201,565 | 14 | 8 | 5.47M | $18.36 $100 Million | 26 | 5 | (4.32M) | |
| Q3 2021 | 2.15K | $0.0 $0 | 6 | 6 | — | 2.15K | ||||
| Q2 2021 | 128M | $4.25 $542 Million | 45 | 13 | 66.1M | $0.0 $0 | 22 | 12 | 61.6M | |